SCHEMBL35721

SCHEMBL35721

C[Si]1(C)COCCOCCOCCOCO1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TTR P02766 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL35617 1.00 TTR (0.32) TTR
SCHEMBL35595 1.00 TTR (0.32) TTR
SCHEMBL8592740 1.00 TTR (0.32) TTR
SCHEMBL759662 0.80
SCHEMBL25345972 0.73
SCHEMBL3856080 0.70
SCHEMBL8592598 0.70
SCHEMBL5071979 0.70
SCHEMBL2411810 0.62
SCHEMBL12062168 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-3020283-A None JP disclosed
US-12606719-B2 Methods and compositions comprising biodegradable cyanoacrylates FEMASYS INC. (US) 2026-04-21 US disclosed
US-20260103623-A1 TWO-PART, CYANOACRYLATE/FREE RADICALLY CURABLE ADHESIVE SYSTEMS HENKEL AG & CO KGAA (DE) 2026-04-16 US disclosed
EP-4061865-B1 TWO COMPONENT (2K) CURABLE COMPOSITION HENKEL AG & CO KGAA (DE) 2026-03-25 EP disclosed
US-12582546-B2 Methods and devices for controlled delivery FEMASYS INC. (US) 2026-03-24 US disclosed
EP-3867323-B1 TWO-PART, CYANOACRYLATE/FREE RADICALLY CURABLE ADHESIVE SYSTEMS HENKEL AG & CO KGAA (DE) 2026-03-18 EP disclosed
US-20260071097-A1 TWO-PART, CYANOACRYLATE/FREE RADICALLY CURABLE ADHESIVE SYSTEMS HENKEL AG & CO KGAA (DE) 2026-03-12 US disclosed
US-20260062590-A1 METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES FOR MEDICAL APPLICATIONS FEMASYS INC (US) 2026-03-05 US disclosed
EP-3837327-B1 TWO-PART, CYANOACRYLATE/FREE RADICALLY CURABLE ADHESIVE SYSTEMS HENKEL AG & CO KGAA (DE) 2025-11-12 EP disclosed
EP-4613213-A2 METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES FOR MEDICAL APPLICATIONS Femasys, Inc. (US) 2025-09-10 EP disclosed
EP-2303342-A2 STABLE AND STERILE TISSUE ADHESIVE COMPOSITION WITH A CONTROLLED HIGH VISCOSITY Adhezion Biomedical, LLC (US) 2011-04-06 EP disclosed
WO-2007049258-A1 THICKENED CYANOACRYLATE COMPOSITIONS LOCTITE (R & D) LIMITED (IE) 2007-05-03 WO disclosed
WO-2004061030-A1 TOUGHENED CYANOACRYLATE COMPOSITIONS LOCTITE (R & D) LIMITED (IE) 2004-07-22 WO disclosed
WO-1998054092-A1 PREPARATION OF ZEOLITE-BOUND FAU STRUCTURE TYPE ZEOLITE AND USE THEREOF EXXON CHEMICAL PATENTS INC. (US) 1998-12-03 WO disclosed
US-5393511-A Faujasite zeolites with hexagonal, cubic or mixed structure SOCIETE NATIONALE ELF AQUITAINE (FR) 1995-02-28 US disclosed
US-5098686-A A porous zeolite as catalysts SOCIETE NATIONALE ELF AQUITAINE (FR) 1992-03-24 US disclosed
JP-H0320283-A METHOD FOR COMPLEXING METAL CATION PETRARCH SYST INC 1991-01-29 JP disclosed
US-4699991-A DISPLACEMENT CATALYSTS PETRARCH SYSTEMS INC. (US) 1987-10-13 US disclosed
US-4596882-A Modified silacrown ethers and methods of making same PETRARCH SYSTEMS INC. (US) 1986-06-24 US disclosed
US-4362884-A Silacrown ethers, method of making same, and use as phase-transfer catalysts PETRARCH SYSTEMS, INC. (US) 1982-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260071097-A1 TWO-PART, CYANOACRYLATE/FREE RADICALLY CURABLE ADHESIVE SYSTEMS AHCYL1, CRKL, MMAB TTR 1125/4885
US-20260062590-A1 METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES FOR MEDICAL APPLICATIONS PGF, ACR, FGB TTR 2318/4885
US-12582546-B2 Methods and devices for controlled delivery PGF, GNRHR, LHCGR TTR 4071/4885
US-12606719-B2 Methods and compositions comprising biodegradable cyanoacrylates MKI67, ACR, PGF TTR 3244/4885
US-20260103623-A1 TWO-PART, CYANOACRYLATE/FREE RADICALLY CURABLE ADHESIVE SYSTEMS HSPA4L, HACL2, CRKL TTR 2256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.